Clinical management of rare brain tumor entities: A retrospective observational study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037081

Enrollment

16000

Registered

2025-06-03

Start date

2025-08-29

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CNS-tumors C71 C72 C79.3 C79.4

Interventions

Group 1: Patients with rare primary or secondary CNS tumors treated between 2000 and 2024 at Heidelberg University Hospital

retrospective analysis of routine clinical data without intervention.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with primary or secondary CNS tumors (ICD-10: C71.-, C72.-, C79.3, C79.4) whose data were available between January 1, 2000, and May 21, 2025, at the Department of Neurology, Heidelberg University Hospital.

Exclusion criteria

Exclusion criteria: No specific exclusion criteria; only incomplete datasets may be excluded if necessary.

Design outcomes

Primary

Measure	Time frame
Treatment modalities, adverse events (according to CTCAE), progression-free survival, and overall survival.	—

Secondary

Measure	Time frame
Therapy modalities, adverse events (classified according to CTCAE), progression-free survival (PFS), and overall survival (OS).	—

Countries

Germany

Contacts

Public ContactTobias Kessler

Universitätsklinikum Heidelberg, Neurologische Klinik

neurologie@med.uni-heidelberg.de06221 56-6999

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026